ClinicalTrials.gg
RecruitingNCT05860478Updated Apr 29, 2024

Wearable Device to Increase Physical Activity Amongst Adults With Pain

An interventional study of Wearable device in Musculoskeletal Chronic Pain Conditions, sponsored by University of West London. Recruiting at 1 site in United Kingdom. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-04-29.

Sponsored by University of West London · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 7 months ago, but the record still lists the study as recruiting.
  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 116 studies in Chronic Pain with a site in United Kingdom — 19 open to participants now, 21 under way, none of them phase 3. Chronic Pain · United Kingdom.

Planned enrollment
41st of 69
40 · median 60
Started
2023
with 7 others
No phase
48 of 116
7 open now
Primary completion
2024-04
later than 3 of 20 live
Registered
96th of 116
by date

Among the 116 studies in Chronic Pain with a site in United Kingdom, this one is the 41st largest by planned enrollment of the 69 interventional ones that give a count, is one of 8 that started in 2023, is one of 48 with no phase, reaches primary completion later than 3 of the 20 other live ones, and was the 96th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

19 of the 116 studies in Chronic Pain with a site in United Kingdom are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 40 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 116 studies in Chronic Pain with a site in United Kingdom, or all of them as a file.
02

Study summary

This protocol is for a pragmatic mixed methods randomized parallel-group exploratory feasibility trial to examine all facets of a proposed future phase III trial on the use of wearable device to increase physical activity and possibly reduce pain amongst middle-aged people with musculoskeletal (MSK) chronic pain. The feasibility study is intended to answer the following research questions:

Question 1 Evaluate the acceptability of all aspect of the study design of wearable devices as an intervention to increase physical activity in middle-aged adults with musculoskeletal chronic pain.

Question 2: Is it feasible and acceptable to use wearable devices as an intervention to increase physical activity in middle-aged adults with musculoskeletal chronic pain? Question 3: How can using wearable device promote physical activity effectively in middle-aged adults with musculoskeletal chronic pain?

Participants will be recruited from a National Health Service (NHS) pain clinic and randomised on a ratio1:3 into control group (standard care) and intervention group (standard care combined with wearable device). The feasibility study will last for 18 months, participants involvement will be for 24 weeks. Patients in both groups can participate in any physical activity, including planned, structured, and repetitive bodily movement exercise or occupational and recreational PA. Qualitative semi-structured interview will be conducted at baseline and week-12, while outcome measures will be conducted at baseline, 4-week, 8-week,12-week, and 24-week for all participants to examine their pain, physical activity, and their responses to the trial. Qualitative interview will be conducted for stakeholders which include clinicians and service managers after all patient data has been collected. This study has the potential to make an original contribution to provide key data on the feasibility, acceptability, and effectiveness of using wearable technology to support physical activity intervention for middle-aged adults with musculoskeletal chromic pain.

03

Conditions studied

  • Musculoskeletal Chronic Pain Conditions

Browse trials for

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient of any gender identity 40-65 years old.
  • Willingness to participate in the trial.
  • Able to understand and speak sufficient English to engage during interviews.
  • They have self-reported persistent or recurrent musculoskeletal pain for three months or longer.
  • Participants will be receiving treatment for musculoskeletal chronic pain.

Exclusion criteria

Exclusion Criteria:

  • Palliative patient.
  • Patients of any gender identity younger than 40-year-old or older than 65-year-old.
  • Patients that are dependent on alcohol or drugs.
  • Involvement with other ongoing studies.
  • Patients unable to complete the questionnaires as judged by the researcher.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    wearable device plus standard care

    Device: Wearable device

  • No intervention
    standard care

Interventions

  • DeviceWearable device

    The wearable device includes a motion sensor, and is worn around the wrist, and the device records a participant's physical activity .

06

What researchers measure

Primary outcomes

  1. Change in Brief Pain Inventory

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  2. Change in Visual Analogue Scale (VAS) of Quality of Life

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  3. Change in Visual Analogue Scale (VAS) of pain

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  4. Change in Numerical Pain Rating Scale (NPRS)

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  5. Change in EuroQol Five-Dimensional Questionnaire (EQ-5D-5L)

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  6. Change in Pain Catastrophising Scale

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  7. Change in The International Physical Activity Questionnaire (IPAQ)

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  8. Change in Chronic Pain Coping Inventory (CPCI)

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

  9. Change in Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)

    Time frame: Participants in both groups will complete outcome measures at baseline (T0), week 4 (T1), week 8 (T2), week 12 (T3), and week 24 (T4)

07

Study locations

1 of 1 sites recruiting
  • Royal London Hospital for Integrated Medicine, UCLH NHS Foundation Trust
    London, WC1N 3HR, United Kingdom
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Apr 2024, 6 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 6 months is below that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2023
First posted
May 16, 2023
StartActual
Oct 6, 2023
Primary completionEst.
Apr 2024
CompletionEst.
Apr 2024
Last update
Apr 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05860478
Lead sponsor
University of West London
Collaborators
Royal London Hospital for Integrated Medicine
Responsible party
John Hughes (Associate Professor, University of West London) — Principal investigator
First posted
May 16, 2023
Start date
Oct 6, 2023
Primary completion
Apr 2024 (estimated)
Completion
Apr 2024 (estimated)
Last update
Apr 29, 2024

Study contacts

John Hughes
Contact
John.Hughes@uwl.ac.uk
02034488883

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion